Cancers du sein T1a,b N0 M0 (RPC 2013)-Reference-Cited by-同舟云学术

Cancers du sein T1a,b N0 M0 (RPC 2013)

Published:2013-12 Issue:12 Volume:15 Page:637-670
ISSN:1292-3818
Container-title:Oncologie
language:fr
Short-container-title:Oncologie

Author:

Cottu P.,Lacroix-Triki M.,Jacot W.,Belkacemi Y.,Dalenc F.,Cottu P.,Rodrigues M.,Coeffic D.

Publisher

Computers, Materials and Continua (Tech Science Press)

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10269-013-2344-4.pdf

Reference164 articles.

1. Aebi S, Davidson T, Gruber G, et al. (2011) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22(Suppl 6): vi12–vi24

2. Amir E, Seruga B, Niraula S, et al. (2011) Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst 103(17): 1299–1309

3. Amir E, Seruga B, Ocaña A, et al. (2011) P2-12-07: pooled analysis of outcomes of T1a/b N0, HER2-Amplified Breast Cancer. Cancer Res 71(24 Suppl): P2–12-07

4. Anderson WF, Chen BE, Jatoi I, Rosenberg PS (2006) Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. Breast Cancer Res Treat 100(1): 121–126

5. Ash DV, Benson EA, Sainsbury JR, et al. (1995) Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group. Clin Oncol (R Coll Radiol) 7(2): 93–96

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes;Frontiers in Oncology;2018-04-17

2. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study;European Journal of Cancer;2017-10

3. Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study;Clinical Breast Cancer;2017-04

4. Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France;Annales de Pathologie;2014-10

5. Juste dix ans;Oncologie;2013-12